1.
TAK1、TAB1表达水平与食管癌患者临床病理参数的相关性分析
Correlations of TAB1 and TAK1 protein expressions and the clinicopathological parameters of the patients with esophageal cancer (n=84)
| Clinicopathological parameters | TAK1 protein | TAB1 protein | Co-expression TAK1/TAB1 | ||||||||
| Low | High | P | Low | High | P | No | Yes | P | |||
| *In accordance with staging of cancer of the esophagus and esophagogastric junction (pathologic TNM staging) for the eighth edition of the AJCC/UICC cancer staging manuals. | |||||||||||
| Gender | 0.386 | 0.174 | 0.425 | ||||||||
| Male | 14 | 32 | 25 | 21 | 27 | 19 | |||||
| Female | 15 | 23 | 15 | 23 | 19 | 19 | |||||
| Age (year) | 0.885 | 0.490 | 0.677 | ||||||||
| < 60 | 8 | 16 | 10 | 14 | 14 | 10 | |||||
| ≥60 | 21 | 39 | 30 | 30 | 32 | 28 | |||||
| Tumor size | 0.020 | 0.062 | 0.001 | ||||||||
| < 5 cm | 25 | 34 | 32 | 27 | 39 | 20 | |||||
| ≥5 cm | 4 | 21 | 8 | 17 | 7 | 18 | |||||
| Location | 0.750 | 0.708 | 0.989 | ||||||||
| Upper | 4 | 7 | 6 | 5 | 6 | 5 | |||||
| Middle | 15 | 33 | 21 | 27 | 26 | 22 | |||||
| Low | 10 | 15 | 13 | 12 | 14 | 11 | |||||
| Invasion depth | 0.005 | 0.012 | 0.035 | ||||||||
| pT 1 | 10 | 4 | 11 | 3 | 11 | 3 | |||||
| pT 2 | 7 | 24 | 16 | 15 | 19 | 12 | |||||
| pT 3 | 12 | 27 | 13 | 26 | 16 | 23 | |||||
| Lymph node metastasis | 0.001 | 0.032 | 0.001 | ||||||||
| Positive | 10 | 40 | 19 | 31 | 20 | 30 | |||||
| Negative | 19 | 15 | 21 | 13 | 26 | 8 | |||||
| Differentiation | 0.084 | 0.161 | 0.426 | ||||||||
| Poor | 5 | 12 | 9 | 8 | 9 | 4 | |||||
| Moderate | 16 | 38 | 22 | 32 | 27 | 27 | |||||
| Well | 8 | 5 | 9 | 4 | 10 | 7 | |||||
| Clinical stage* | 0.000 | 0.037 | 0.003 | ||||||||
| Ⅰ | 9 | 2 | 9 | 2 | 10 | 1 | |||||
| Ⅱ | 13 | 16 | 14 | 15 | 19 | 10 | |||||
| Ⅲ | 7 | 37 | 17 | 27 | 17 | 27 | |||||